首页> 外文期刊>Life sciences >Red blood cells participate in the metabolic clearance of catecholamines in the rat.
【24h】

Red blood cells participate in the metabolic clearance of catecholamines in the rat.

机译:红细胞参与大鼠中儿茶酚胺的代谢清除。

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

The aim of the present study was to investigate the possible role of erythrocytes in the metabolic clearance of catecholamines (CAs) in the rat. Intravenous infusion of exogenous CAs (dopamine -DA-, norepinephrine -NE-, or epinephrine -Epi-) was carried out at increasing doses to cover a range of plasma concentrations from the lower to the upper physiological and to pharmacological levels. Whatever the mechanism(s) underlying the CAs erythrocyte/plasma balance: 1. it seemed more efficient at lower concentrations of CAs; 2. it reached an apparent plateau where plasma and erythrocyte concentrations were not statistically different; 3. finally, saturation was suggested when further increase in plasma concentration was associated with a lower response in erythrocytes. This series of experiments confirms previous reported results with human erythrocytes and suggests that rat erythrocytes could transport CAs from their sites of release to their sites of elimination. In a second series of experiments, the intra-erythrocyte metabolism of CAs was investigated. DA was strikingly increased in plasma and in erythrocytes 2 hours after 1,2-dimethyl-3-hydroxy-4-pyridone (CP20), 100 mg/kg i.p., known to inhibit catechol-O-methyl transferase. Our data demonstrate an increase in glucuro-conjugated DA in vivo (24 hours after CP20 injection) as well as in vitro (3 hours incubation at 37 degrees C), suggesting activation of the glucuroconjugating pathway. Increased glucuroconjugated DA after in vitro incubation demonstrates intra-erythrocyte synthesis while increased concentration in Ringer-Hepes medium demonstrates an inside-out transport of glucuro-conjugate. These data are the first evidence in favour of an intra-erythrocyte glucuro-conjugation of CAs in the rat.
机译:本研究的目的是研究红细胞在大鼠儿茶酚胺(CAs)代谢清除中的可能作用。静脉内注射外源性CA(多巴胺-DA-,去甲肾上腺素-NE-或肾上腺素-Epi-)剂量要从生理至药理学水平的低到高范围内。无论CA的红细胞/血浆平衡存在何种机制:1.在较低的CA浓度下似乎更有效; 2.达到明显的高原,血浆和红细胞浓度无统计学差异; 3.最后,当血浆浓度进一步升高与红细胞反应降低相关时,提示饱和。这一系列的实验证实了先前报道的有关人类红细胞的结果,并表明大鼠红细胞可以将CA从其释放位点转运至其消除位点。在第二系列实验中,研究了CA的红细胞内代谢。 1,2-二甲基-3-羟基-4-吡啶酮(CP20)(已知抑制儿茶酚-O-甲基转移酶)100 mg / kg腹腔注射后2小时,血浆和红细胞中的DA显着增加。我们的数据表明体内(CP20注射后24小时)以及体外(在37摄氏度下孵育3小时)葡萄糖结合的DA均增加,表明葡萄糖结合途径的激活。体外孵育后,葡糖醛酸结合物DA的增加表明了红细胞内的合成,而在林格-赫普斯培养基中浓度的增加表明了葡糖醛酸结合物的由内而外的转运。这些数据是支持大鼠中CA的红细胞葡萄糖内结合的第一个证据。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号